Vectura Fertin Pharma
Thordis Gudmundsdottir is currently the VP Global Head of Regulatory Affairs & Pharmacovigilance at Vectura Fertin Pharma since October 2023. Prior to this, Thordis has held various roles such as Regulatory Affairs Consultant at an Independent company, Head of Regulatory Affairs CKD & Hematology at CSL Vifor, and VP Regulatory & Quality Affairs EMEA at Lupin Atlantis Holdings SA. Thordis also has a background in pharmaceutical sciences, with an MSc (pharm) from Háskóli Íslands and is currently pursuing an Executive MBA in Healthcare management from HEC Lausanne.
This person is not in any offices
Vectura Fertin Pharma
1 followers
We aim to be a leader in the health and wellness space by developing a pipeline of proprietary products that we can commercialize. Our mission is to enhance life through the delivery of seamless health experiences. Vectura Fertin Pharma brings together Vectura’s expertise in inhalation and Fertin Pharma’s leadership in oral and intra-oral delivery systems to build upon products that exist today and make them better for consumers and patients tomorrow. We will take proven, safe, and effective therapies, unlock their true potential through the application of new and existing consumer and patient-led delivery systems, and commercialize them through proprietary wellness and healthcare brands or in partnership with other pharmaceutical companies. For more, visit our website at https://www.vecturafertinpharma.com.